Reference : Cyclosporin A, rapamycin and FK506 decrease prolactin release from rat pituitary cell...
Scientific journals : Article
Life sciences : Biochemistry, biophysics & molecular biology
Cyclosporin A, rapamycin and FK506 decrease prolactin release from rat pituitary cells in primary culture
Wera, S. [> > > >]
Zheng, L. [> > > >]
Hooghe-Peters, E. L. [> > > >]
Belayew, A. [> > > >]
Martial, Joseph mailto [Université de Liège - ULg > Département des sciences de la vie > GIGA-R : Biologie et génétique moléculaire >]
Velkeniers, B. [> > > >]
Endocrine Research
Taylor & Francis
Yes (verified by ORBi)
[en] Animals ; Cells, Cultured ; Cyclosporine/*pharmacology ; Female ; Immunosuppressive Agents/*pharmacology ; Kinetics ; Pituitary Gland, Anterior/*drug effects/*secretion ; Polyenes/*pharmacology ; Prolactin/*secretion ; Rats ; Rats, Wistar ; Sirolimus ; Tacrolimus/*pharmacology
[en] It is at present well established that prolactin exerts a non-specific immunoactivating function. In this work we tested whether the immunosuppressant drugs cyclosporin A, FK506 and rapamycin influence prolactin release from rat pituitary cells in primary culture. The tested drugs had no effect on the prolactin release measured during a 2h incubation period, indicating that they do not influence the secretion of prolactin from intracellular stores into the culture medium. During longer incubation times (48h), however, prolactin release was diminished to 56% +/- 18 (10 microM cyclosporin A), 64% +/- 14 (1 microM rapamycin) or 64% +/- 7 (1 microM FK506), suggesting an effect on prolactin production. At these drug concentrations no toxic effects were observed. The data indicate that inhibition of pituitary prolactin synthesis might contribute to the immunosuppressant action of cyclosporin A, rapamycin and FK506.

There is no file associated with this reference.

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.